These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7870877)

  • 1. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.
    Papp M; Willner P; Muscat R
    Psychopharmacology (Berl); 1993; 110(1-2):159-64. PubMed ID: 7870877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.
    Papp M; Muscat R; Willner P
    Psychopharmacology (Berl); 1993; 110(1-2):152-8. PubMed ID: 7870876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant.
    D'Aquila P; Monleon S; Borsini F; Brain P; Willner P
    Eur J Pharmacol; 1997 Dec; 340(2-3):121-32. PubMed ID: 9537806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.
    Willner P; Lappas S; Cheeta S; Muscat R
    Psychopharmacology (Berl); 1994 Aug; 115(4):454-62. PubMed ID: 7871089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.
    Muscat R; Papp M; Willner P
    Psychopharmacology (Berl); 1992; 109(4):433-8. PubMed ID: 1365858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists.
    Rowlett JK; Mattingly BA; Bardo MT
    Synapse; 1995 Jul; 20(3):209-16. PubMed ID: 7570352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole-induced behavioral sensitization is enhanced by prior scheduled exposure to sucrose: A multi-variable examination of locomotor activity.
    Foley KA; Fudge MA; Kavaliers M; Ossenkopp KP
    Behav Brain Res; 2006 Feb; 167(1):49-56. PubMed ID: 16198008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intraaccumbens injections of dopamine agonists and antagonists on sucrose and sucrose-ethanol reinforced responding.
    Hodge CW; Samson HH; Tolliver GA; Haraguchi M
    Pharmacol Biochem Behav; 1994 May; 48(1):141-50. PubMed ID: 7913224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D(2) receptors and ingestive behavior: brainstem mediates inhibition of intraoral intake and accumbens mediates aversive taste behavior in male rats.
    Sederholm F; Johnson AE; Brodin U; Södersten P
    Psychopharmacology (Berl); 2002 Mar; 160(2):161-9. PubMed ID: 11875634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 104(2):201-7. PubMed ID: 1831560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.
    Cheeta S; Broekkamp C; Willner P
    Psychopharmacology (Berl); 1994 Dec; 116(4):523-8. PubMed ID: 7701058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding.
    Hodge CW; Chappelle AM; Samson HH
    Alcohol Clin Exp Res; 1996 Dec; 20(9):1631-8. PubMed ID: 8986215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
    Einat H; Szechtman H
    Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress.
    D'Aquila PS; Peana AT; Carboni V; Serra G
    J Psychopharmacol; 2000; 14(4):347-52. PubMed ID: 11198051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus.
    Weissenborn R; Deroche V; Koob GF; Weiss F
    Psychopharmacology (Berl); 1996 Aug; 126(4):311-22. PubMed ID: 8878347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.
    Papp M; Willner P; Muscat R
    Psychopharmacology (Berl); 1991; 104(2):255-9. PubMed ID: 1876670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency.
    Szumlinski KK; Allan M; Talangbayan H; Tracey A; Szechtman H
    Psychopharmacology (Berl); 1997 Nov; 134(2):193-200. PubMed ID: 9399384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.